SEC Contract Filing

Filing Date: 2021-12-23

Document Content:
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>10
<FILENAME>tm2136160d1_ex10-9.htm
<DESCRIPTION>EXHIBIT 10.9
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.9</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FIRST AMENDMENT TO EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This First Amendment to Employment Agreement (this
 &ldquo;<B>First Amendment</B>&rdquo;) is entered into as of December&nbsp;22, 2021 (the &ldquo;<B>Amendment Effective Date</B>&rdquo;),
between Blueprint Medicines Corporation, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and Percy H. Carter, Ph. D., MBA (the
 &ldquo;<B>Executive</B>&rdquo;). Capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Employment
Agreement (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company and the Executive are parties
to the Employment Agreement entered into on April&nbsp;27, 2021 (the &ldquo;<B>Employment Agreement</B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company and the Executive desire to
amend the Employment Agreement as set forth below;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, for good and valuable consideration,
the receipt of which is hereby confirmed, the Company and the Executive agree that the Employment Agreement is amended as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Section&nbsp;5(a)&nbsp;of
the Employment Agreement shall be amended and restated as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Sale Event</U>. During the Term, if during
the Protection Period, the Executive&rsquo;s employment is terminated by the Company without Cause as provided in Section&nbsp;3(d)&nbsp;or
the Executive terminates employment for Good Reason as provided in Section&nbsp;3(e), then, subject to the signing of the Separation Agreement
and Release by the Executive and the Separation Agreement and Release becoming irrevocable, all within 60 days after the Date of Termination,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #424242">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Company shall pay the Executive a lump sum in cash in an amount equal to the sum of (A)&nbsp;one and one-half (1.5) times the Executive&rsquo;s
current Base Salary (or the Executive&rsquo;s Base Salary in effect immediately prior to the Sale Event, if higher) plus (B)&nbsp;one
and one-half (1.5) times the Executive&rsquo;s Target Incentive Compensation ((A)&nbsp;and (B)&nbsp;together, the &ldquo;Change in Control
Payment&rdquo;), provided any Change in Control Payment shall be less the Restrictive Covenants Agreement Setoff, if applicable; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #424242">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>if
the Executive was participating in the Company&rsquo;s group health (medical, dental and/or vision) plan immediately prior to the Date
of Termination and elects COBRA health continuation, then the Company shall pay to the Executive a monthly cash payment for eighteen (18)
months or the Executive&rsquo;s COBRA health continuation period, whichever ends earlier, in an amount equal to the monthly employer contribution
that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #424242">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>all
time-based stock options and other time-based stock-based awards held by the Executive shall accelerate and become fully exercisable or
non-forfeitable as of the Date of Termination; provided that, if any stock options or other stock-based awards held by the Executive prior
to the Effective Date have accelerated vesting terms that are more favorable to the Executive than those set forth in this Section&nbsp;5(a)(iii),
the vesting terms of those stock options or other stock-based awards shall apply as opposed to the accelerated vesting terms set forth
in this Section&nbsp;5(a)(iii)&nbsp;solely with respect to such awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif;